EP2886108
Bestuð lyfjasamsetning til meðhöndlunar á bólgubreytingum í vélindanu
Status:
EP einkaleyfi: Endurútgefin þýðing EP einkaleyfisEP appl. date:
23.12.2013EP published:
6.2.2019EP application number:
13199278.6
EP translation filed:
25.2.2019Grant published:
15.3.2019EPO information:
European Patent Register
Max expiry date:
22.12.2033Expiry date:
22.12.2026Next due date:
31.12.2026
Title:
Optimised pharmaceutical formula for the treatment of inflammatory changes of the esophagus
Timeline
Today
23.12.2013EP application
6.2.2019EP Publication
25.2.2019Translation submitted
15.3.2019Registration published
22.12.2026Expires
Owner
Name:
Dr. Falk Pharma GmbHAddress:
Leinenweberstrasse 5, 79108, Freiburg, DE
Inventor
Name:
Greinwald, RolandAddress:
Kenzingen, DE
Name:
Müller, RalphAddress:
Freiburg, DE
Name:
Pröls, MarkusAddress:
Freiburg/Breisgau, DE
Name:
Wilhelm, RudolfAddress:
Bischweier, DE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Classification
Categories:
A61K 9/46, A61K 9/00, A61K 31/58, A61K 9/20
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 13.12.2019
Expires: 22.12.2020
Payer: Guðjón Styrkársson
Number: 8
Paid: 14.12.2020
Expires: 22.12.2021
Payer: Patice ehf.
Number: 9
Paid: 16.12.2021
Expires: 22.12.2022
Payer: Patice ehf.
Number: 10
Paid: 22.12.2022
Expires: 22.12.2023
Payer: Árnason Faktor ehf.
Number: 11
Paid: 15.12.2023
Expires: 22.12.2024
Payer: Árnason Faktor ehf.
Number: 12
Paid: 13.12.2024
Expires: 22.12.2025
Payer: Árnason Faktor ehf.
Number: 13
Paid: 19.12.2025
Expires: 22.12.2026
Payer: Árnason Faktor ehf.